Therapeutic vasculogenesis in patients with critical limb ischaemia (CLI) is an experimental method with good term results. Successful vasculogenesis is achieved by transcatheter intra-arterial administration of autologous bone marrow mononuclear cells (BMMC) directly into the ischemic foot.